Literature DB >> 14611628

Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium.

Kurt J Sales1, Henry N Jabbour.   

Abstract

Prostaglandins are bioactive lipids produced from arachidonic acid by cyclooxygenase (COX) enzymes and specific terminal prostanoid synthase enzymes. After biosynthesis, prostaglandins exert an autocrine-paracrine function by coupling to specific prostanoid G protein-coupled receptors to activate intracellular signalling and gene transcription. For many years, prostaglandins have been recognized as key molecules in reproductive biology by regulating ovulation, endometrial physiology and proliferation of endometrial glands and menstruation. More recently, a role for COX enzymes and prostaglandins has been ascertained in reproductive tract pathology, including carcinomas, menorrhagia, dysmenorrhoea and endometriosis. Although the mechanism by which prostaglandins modulate these pathologies is still unclear, a large body of evidence supports a role for COX enzymes, prostaglandins and prostaglandin receptor signalling pathways in angiogenesis, apoptosis and proliferation, tissue invasion and metastases and immunosuppression. Here, an overview is provided of some of the findings from these studies with specific emphasis on the role of COX enzymes, prostaglandin E(2) and F(2alpha) in disorders of endometrial proliferation and menstruation in non-pregnant women.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611628      PMCID: PMC2695735          DOI: 10.1530/rep.0.1260559

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  81 in total

Review 1.  Inhibition of cyclooxygenase: a novel approach to cancer prevention.

Authors:  K Subbaramaiah; D Zakim; B B Weksler; A J Dannenberg
Journal:  Proc Soc Exp Biol Med       Date:  1997-11

2.  Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

Authors:  H Lim; B C Paria; S K Das; J E Dinchuk; R Langenbach; J M Trzaskos; S K Dey
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

3.  Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.

Authors:  H S Samaha; G J Kelloff; V Steele; C V Rao; B S Reddy
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

4.  Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma.

Authors:  B J Tong; J Tan; L Tajeda; S K Das; J A Chapman; R N DuBois; S K Dey
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

5.  Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.

Authors:  B M Forman; J Chen; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

6.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

Authors:  J E Dinchuk; B D Car; R J Focht; J J Johnston; B D Jaffee; M B Covington; N R Contel; V M Eng; R J Collins; P M Czerniak
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

7.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

Authors:  M Tsujii; R N DuBois
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

8.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

Authors:  R Langenbach; S G Morham; H F Tiano; C D Loftin; B I Ghanayem; P C Chulada; J F Mahler; C A Lee; E H Goulding; K D Kluckman; H S Kim; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

9.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Authors:  M Tsujii; S Kawano; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.

Authors:  R N DuBois; J Shao; M Tsujii; H Sheng; R D Beauchamp
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

View more
  37 in total

1.  Alterations in eicosanoid composition during embryonic development in the chorioallantoic membrane of the American alligator (Alligator mississippiensis) and domestic chicken (Gallus gallus).

Authors:  Theresa M Cantu; John A Bowden; Jacob Scott; Jimena B Pérez-Viscasillas; Kevin Huncik; Matthew P Guillette; Louis J Guillette
Journal:  Gen Comp Endocrinol       Date:  2016-07-09       Impact factor: 2.822

2.  Altered white matter microarchitecture in the cingulum bundle in women with primary dysmenorrhea: A tract-based analysis study.

Authors:  Jixin Liu; Hongjuan Liu; Junya Mu; Qing Xu; Tao Chen; Wanghuan Dun; Jing Yang; Jie Tian; Li Hu; Ming Zhang
Journal:  Hum Brain Mapp       Date:  2017-06-07       Impact factor: 5.038

3.  Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.

Authors:  Cédric Carli; Christine N Metz; Yousef Al-Abed; Paul H Naccache; Ali Akoum
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

4.  Deficiency of immunophilin FKBP52 promotes endometriosis.

Authors:  Yasushi Hirota; Susanne Tranguch; Takiko Daikoku; Akiko Hasegawa; Yutaka Osuga; Yuji Taketani; Sudhansu K Dey
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

5.  Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.

Authors:  Yumei Chen; Bo Zhu; Hongping Zhang; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Sci       Date:  2013-05-23       Impact factor: 3.060

Review 6.  Phosphatidic acid phosphohydrolase in the regulation of inflammatory signaling.

Authors:  Andrej Grkovich; Edward A Dennis
Journal:  Adv Enzyme Regul       Date:  2009

7.  Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.

Authors:  Wesam M Osman; Nermeen S Youssef
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

8.  F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells.

Authors:  K J Sales; S C Boddy; H N Jabbour
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

9.  Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.

Authors:  Kurt J Sales; David Maldonado-Pérez; Vivien Grant; Rob D Catalano; Martin R Wilson; Pamela Brown; Alistair R W Williams; Richard A Anderson; E Aubrey Thompson; Henry N Jabbour
Journal:  Biochim Biophys Acta       Date:  2009-10-09

10.  EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway.

Authors:  A B Abera; K J Sales; R D Catalano; A A Katz; H N Jabbour
Journal:  Cell Signal       Date:  2009-09-25       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.